# RIVASTIGMINE TARTRATE
> **ANDA077131** · Abbreviated New Drug Application (Generic) · Sponsor: SUN PHARM · Approved 2007-10-22
## Drug
- **FDA Application Number:** ANDA077131
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** RIVASTIGMINE TARTRATE
- **Generic name:** RIVASTIGMINE TARTRATE
- **Active ingredients:** RIVASTIGMINE TARTRATE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** SUN PHARM
- **Manufacturer:** Sun Pharmaceutical Industries, Inc.
- **First approval:** 2007-10-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=077131)
---
*MORVS · CC0 1.0*